Cancer and Allergy Foundation Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2007
NCT01959438
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now